COLL Collegium Pharmaceutical, Inc.

NASDAQ
$25.93

Collegium Pharmaceutical, Inc. (COLL) is expected to report earnings on February 4, 2027, before the market open. The consensus earnings estimate is $1.61 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.7% since its last earnings release on November 5, 2026.

Collegium Pharmaceutical Beat Consensus Estimates, Reaffirms Revenue Guidance
Thursday, November 5, 2026 · 7:30 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · 7:30 AM ET
Earnings Whisper
-
vs $1.61
Rev est $223.68M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $24.98

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Collegium Pharmaceutical, Inc.

Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Charts powered in part by Lightweight Charts™ by TradingView.